The Horizons Tracker

OCTOBER 21, 2021

The market for PlayStation2 games was chosen because the lack of self-publishing opportunities at the time meant that developers had to partner with publishers to get their games to market. Developers typically look for a couple of things when choosing a publishing partner. Power play. Making the trade-off. Securing help.

Entrepreneur 99

Entrepreneur Biotechnology Pharmaceuticals Marketing 99

Career Advancement

MAY 25, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. To thrive in this role, he needed to develop new skills for dealing with a never-ending stream of demands. His responsibilities and the number of decisions he had to make drastically increased.

Tips 156

Tips Biotechnology Objective Learning-by-Doing 156

Career Advancement

SEPTEMBER 27, 2021

Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. To thrive in this role, he needed to develop new skills for dealing with a never-ending stream of demands. His responsibilities and the number of decisions he had to make drastically increased.

Tips 120

Tips Biotechnology Objective Learning-by-Doing 120

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. At the time, Gomez commented, “It is a privilege for me to join an organization that is focused on developing transformative medicines to address major public healthcare challenges worldwide.” The Moderna Success Story. Moderna Inc.,

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

First Friday Book Synopsis

MARCH 8, 2011

John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders. He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health.

Biotechnology 85

Biotechnology Pharmaceuticals Consultative Industry 85

CO2

DECEMBER 15, 2023

This connection is often the catalyst for the most profound growth and development in a leader’s journey. These studies provide empirical evidence on how executive coaching significantly impacts leadership development, performance, and organizational success. These research findings align perfectly with the ethos of CO2 Coaching.

Executive Coaching 78

Executive Coaching Execution Commitment Biotechnology 78

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. This has prompted many of the fastest growing companies of our age to congregate in the same places.

Biotechnology 56

Biotechnology Human Capital Travel Entrepreneur 56

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. After a few experiments, they pronounced it ready to ship to customers, and did not need to go through a formal development process. I cringed when I heard the story.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. Training and development programs almost universally focus factory-like on inputs and outputs — absorb curriculum, check a box; learn a skill, advance a rung; submit to assessment, fix a problem.

Development 17

Development Biotechnology CIO Short-term 17

Skip Prichard

JULY 22, 2019

Tesla’s genius and education led him to develop the foundations for electric induction motors, wireless telegraphy, radios, neon lamps, and remote control. When Edison developed a commercially viable light bulb, he was able to convince Morgan to advance him $30,000 for the Edison Electric Light Company. Championing change is hard.”

Innovation 80

Innovation Social Capital Reputation How To 80

Strategy Driven

MAY 12, 2021

Similarly, the increased development of 3D games, 3D mobile devices, and 3D movies has stimulated the demand for true 3D displays both in consumer and enterprise applications. Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential.

Technology 103

Technology Content Video Globalization 103

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Are You Using Dialects To Develop Your Employees’ Skills? You’ll be glad you did.

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Tanveer Naseer

JUNE 2, 2015

Dan was the president of a biotechnology company where I served in my first middle management role.

Biotechnology 100

Biotechnology Learning-by-Doing Audience Middle Management 100

Harvard Business Review

MARCH 17, 2014

Under the broad umbrella of impact investments lie myriad sectors, asset types, and investment products, most of which still need to be developed and understood. First, impact investing needs time to develop. Impact Investing in the Future: Developed clusters across the spectrum. sanitation, housing, mobile banking).

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. IT is good for developing countries — it empowers people and improves their lives.

Information Technology 14

Information Technology Technology Information Trends 14

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

JUNE 4, 2018

” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. ” Unfortunately, this goal hasn’t been met. industries face acute skills shortages.

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Because of three significant challenges innovators face in emerging markets: Innovation ecosystems are not well-developed.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JUNE 21, 2013

We also find that companies in developed areas plan to hire in other developed regions (e.g., North America in Western Europe and vice versa) and many countries in developing regions are moving into developed regions (e.g., Asia into North America). All this presents a special challenge for Western European companies.

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. You need to be plugged into the local informal networks. Doing so requires being there.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. We might expect the regions with the lowest overall averages to be those dominated by developing or emerging economies.

Talent Management 8

Talent Management Company Telecommunications Management 8

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. From computer hardware and software to technology service providers, app developers and data processing, the potential for growth is seemingly limitless.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. In fact, she was not brought into the discussion until campaigns were far along in their development and it was too late for her to influence the marketing team’s decisions. Do You Really Need to Hold That Meeting? Elizabeth Grace Saunders.

Restructuring 13

Restructuring How To Compliance Biotechnology 13

Harvard Business Review

MARCH 1, 2011

And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice. And biotechnology and medical devices are among the leading areas for venture capital funding. Fortunes have been made from implants, surgical instruments, and artificial products.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

FEBRUARY 22, 2013

Your company has just developed an amazing new product. Years of development, energy, and, of course, money have gone into it. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. He developed the next generation form of Provigil prior to the patent expiration.

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

SEPTEMBER 21, 2018

Only 13% of directors in the energy and utilities industry consider innovation to be a major strategic challenge, but the swift growth of renewable energy companies and such developments as the use of drones for monitoring oil and gas production suggest that no industry is impervious to the forces of innovation.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). Second, the world of start-ups is narrowly focused. That’s not to say big companies should go it alone.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. Too often, any thought of changing a culture, never mind rebuilding it, seems like a Sisyphean task; the weight of the status quo ultimately rolls back and crushes such efforts.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

JUNE 3, 2013

Many wonder why an academy company like P&G, historically known for developing talent, did not, or was not able to, promote a successor from within its ranks. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Where was its leadership bench?

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

OCTOBER 1, 2014

With an eye towards broadening and amplifying this conversation, we have developed a Scale Up Declaration , which we offer as a rallying point for what the entrepreneurship discussion should focus on, and what it should aim to accomplish.

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

MAY 10, 2016

The rationale for this approach is highlighted when you compare, for example, the different approaches to M&A employed by a number of legacy pharmaceutical companies and by some relatively newer players in the biotechnology industry. For example, Gilead grew from a tiny startup developing H.I.V.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

AUGUST 17, 2015

When you put all these pieces together around education and health care, it’s clear that Cuba is likely a champion of investment in the development of human capital—but for the last 50 years it has an extremely low economic return on this investment. And secondly, the business model for Cuban biotechnology has been laughably bad.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

FEBRUARY 16, 2016

However, outside North America they tend to be more optimistic about emerging economies: 36% of directors in Asia, 24% of directors in Australia and New Zealand, and 23% of directors in Africa predict faster growth in emerging economies than in developed countries in the next three years.

Politics 8

Politics Telecommunications Policies Biotechnology 8